What does PHARMACIE DELVIGNE DOUMONT do?

PHARMACIE DELVIGNE DOUMONT is a pharmacy in Genappe. Public Limited, started on 11 January 2001, 1 establishment.

What is the address of PHARMACIE DELVIGNE DOUMONT?

The registered office of PHARMACIE DELVIGNE DOUMONT is located at Rue de Bruxelles 47, 1470 Genappe.

Is PHARMACIE DELVIGNE DOUMONT still active?

Yes. According to the CBE (30 October 2026) PHARMACIE DELVIGNE DOUMONT is active, legal situation “Normale toestand”, started on 11 January 2001.

Is PHARMACIE DELVIGNE DOUMONT registered on Peppol?

Yes, PHARMACIE DELVIGNE DOUMONT is registered on the Peppol network with ID 0208:0473801448.

What is the enterprise number of PHARMACIE DELVIGNE DOUMONT?

The enterprise number of PHARMACIE DELVIGNE DOUMONT is BE0473801448.

When was PHARMACIE DELVIGNE DOUMONT founded?

PHARMACIE DELVIGNE DOUMONT was founded on 11 January 2001.

Who are the directors of PHARMACIE DELVIGNE DOUMONT?

According to the 2025 annual accounts, the directors of PHARMACIE DELVIGNE DOUMONT are: CORINNE DELVIGNE, RENAUD DOUMONT.

Is PHARMACIE DELVIGNE DOUMONT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 January 2001; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE DELVIGNE DOUMONT make in 2025?

PHARMACIE DELVIGNE DOUMONT posted a profit after taxes of € 66,530 in financial year 2025.

What is the revenue of PHARMACIE DELVIGNE DOUMONT?

As a small company, PHARMACIE DELVIGNE DOUMONT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 189,736.

How much does an employee at PHARMACIE DELVIGNE DOUMONT earn?

The average wage cost per full-time employee at PHARMACIE DELVIGNE DOUMONT was € 45,600 in 2025: staff costs of € 77,461 for 1.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE DELVIGNE DOUMONT have?

According to the 2025 annual accounts, PHARMACIE DELVIGNE DOUMONT has 1.7 full-time equivalents (FTE).

PHARMACIE DELVIGNE DOUMONT (Public Limited) - Genappe

Dossier PHARMACIE DELVIGNE DOUMONT, printed on 30 October 2026 from databakkes.be/en/0473801448/pharmacie-delvigne-doumont. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMACIE DELVIGNE DOUMONT from Genappe, company number BE0473801448, closed financial year 2025 with a result of € 66,530 after tax. For that financial year PHARMACIE DELVIGNE DOUMONT recorded a gross margin of € 189,736 and equity of € 188,029. Compared with financial year 2024, the result moved from € 103,905 to € 66,530. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Growing

€ 188,029

▲ 55% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 66,530

▼ 36% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 164,871

▲ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 125,981.

People and assets in 2025

Full-time equivalents

1.7

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 77,461

▲ 1% vs 2024

€ 45,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,736

▼ 44% vs 2024

Of which on lease € 432.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 73,301

▼ 13% vs 2024

€ 11,879 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 157,289

▲ 14% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 13,183

▼ 22% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 174,948 Gross margin 2022: € 174,948 First fiscal year in the series	€ 211,290 Gross margin 2023: € 211,290 ▲ 21% vs 2022 (€ 174,948) Favourable step	€ 239,138 Gross margin 2024: € 239,138 ▲ 13% vs 2023 (€ 211,290) Favourable step	€ 189,736 Gross margin 2025: € 189,736 ▼ 21% vs 2024 (€ 239,138) Unfavourable step	▼ 21%
Profit after taxes	€ 41,007 Profit after taxes 2022: € 41,007 First fiscal year in the series	€ -453,745 Profit after taxes 2023: € -453,745 ▼ € 494,753 vs 2022 (€ 41,007) Unfavourable step	€ 103,905 Profit after taxes 2024: € 103,905 ▲ € 557,650 vs 2023 (€ -453,745) Favourable step	€ 66,530 Profit after taxes 2025: € 66,530 ▼ 36% vs 2024 (€ 103,905) Unfavourable step	▼ 36%
Equity	€ 486,340 Equity 2022: € 486,340 First fiscal year in the series	€ 32,595 Equity 2023: € 32,595 ▼ 93% vs 2022 (€ 486,340) Unfavourable step	€ 121,500 Equity 2024: € 121,500 ▲ 273% vs 2023 (€ 32,595) Favourable step	€ 188,029 Equity 2025: € 188,029 ▲ 55% vs 2024 (€ 121,500) Favourable step	▲ 55%
Total debts	€ 1,498,287 Total debts 2022: € 1,498,287 First fiscal year in the series	€ 361,527 Total debts 2023: € 361,527 ▼ 76% vs 2022 (€ 1,498,287) Favourable step	€ 288,089 Total debts 2024: € 288,089 ▼ 20% vs 2023 (€ 361,527) Favourable step	€ 263,658 Total debts 2025: € 263,658 ▼ 8% vs 2024 (€ 288,089) Favourable step	▼ 8%
Cash	€ 80,195 Cash 2022: € 80,195 First fiscal year in the series	€ 159,369 Cash 2023: € 159,369 ▲ 99% vs 2022 (€ 80,195) Favourable step	€ 152,968 Cash 2024: € 152,968 ▼ 4% vs 2023 (€ 159,369) Unfavourable step	€ 164,871 Cash 2025: € 164,871 ▲ 8% vs 2024 (€ 152,968) Favourable step	▲ 8%
Land & buildings	€ 53,896 Land & buildings 2022: € 53,896 First fiscal year in the series	€ 49,043 Land & buildings 2023: € 49,043 ▼ 9% vs 2022 (€ 53,896) Unchanged	€ 44,190 Land & buildings 2024: € 44,190 ▼ 10% vs 2023 (€ 49,043) Unchanged	€ 39,336 Land & buildings 2025: € 39,336 ▼ 11% vs 2024 (€ 44,190) Unchanged	▼ 11%
Retained profit	€ 424,292 Retained profit 2022: € 424,292 First fiscal year in the series	€ -29,454 Retained profit 2023: € -29,454 ▼ € 453,745 vs 2022 (€ 424,292) Unfavourable step	€ 59,452 Retained profit 2024: € 59,452 ▲ € 88,905 vs 2023 (€ -29,454) Favourable step	€ 125,981 Retained profit 2025: € 125,981 ▲ 112% vs 2024 (€ 59,452) Favourable step	▲ 112%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 15,000 Dividend 2024: € 15,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 15,000) Unchanged	▼ 100%
Bank debt	€ 823,425 Bank debt 2022: € 823,425 First fiscal year in the series	€ 100,791 Bank debt 2023: € 100,791 ▼ 88% vs 2022 (€ 823,425) Favourable step	€ 84,684 Bank debt 2024: € 84,684 ▼ 16% vs 2023 (€ 100,791) Favourable step	€ 73,301 Bank debt 2025: € 73,301 ▼ 13% vs 2024 (€ 84,684) Favourable step	▼ 13%
Balance sheet total	€ 1,984,627 Balance sheet total 2022: € 1,984,627 First fiscal year in the series	€ 394,122 Balance sheet total 2023: € 394,122 ▼ 80% vs 2022 (€ 1,984,627) Unchanged	€ 409,589 Balance sheet total 2024: € 409,589 ▲ 4% vs 2023 (€ 394,122) Unchanged	€ 451,687 Balance sheet total 2025: € 451,687 ▲ 10% vs 2024 (€ 409,589) Unchanged	▲ 10%
Employees (FTE)	1.7 Employees (FTE) 2022: 1.7 First fiscal year in the series	1.7 Employees (FTE) 2023: 1.7 Unchanged (1.7) Unchanged	1.7 Employees (FTE) 2024: 1.7 Unchanged (1.7) Unchanged	1.7 Employees (FTE) 2025: 1.7 Unchanged (1.7) Unchanged

Key figures of PHARMACIE DELVIGNE DOUMONT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DELVIGNE DOUMONT?

What happened at PHARMACIE DELVIGNE DOUMONT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 CORINNE DELVIGNE stepped down as director. NBB
2029 RENAUD DOUMONT stepped down as director. NBB
Jun 30, 2026 New annual accounts for financial year 2025: profit of € 66,530 (▼ 36% vs 2024). Source: NBB ↗
2014 CORINNE DELVIGNE became a director. NBB
2014 RENAUD DOUMONT became a director. NBB
May 17, 2001 New establishment in Genappe. KBO
Jan 11, 2001 Start of the company according to the CBE. KBO

In short

From € 41,007 profit in 2022 to € 66,530 profit in 2025.

Paid € 96,177 in corporate taxes since 2022.

Best year ever: 2024, with € 103,905 profit.

On average € 111,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

CORINNE DELVIGNE

Managing director

since 2014 · until 2029

RENAUD DOUMONT

Director

Also active at: GENAPPE PHARMA INVEST, PHARMACIE DU LOTHIER

since 2014 · until 2029

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Bruxelles 47

1470 Genappe

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0473.801.448

VAT number

BE 0473.801.448

Registered office

Rue de Bruxelles 47, 1470 Genappe

Names & denominations

PHARMACIE DELVIGNE DOUMONT · DOUDEL

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

11 January 2001

Peppol

Active · Active since 12 Jun 2024

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE DELVIGNE DOUMONT